Call Us +15878829858 | info@remediumpharmacy.com

Investor Relations

Remedium Bio Technology To Join Forces With Strategic Partner To Capitalize On The Canadian Adult Use Cannabis Market

Date Posted: November 23 2018

Welcome to Remedium Bio-Technology's Investor Relations' page.
Our Investor Relations' program is key to our company's future success and we endeavor to build long-lasting, mutually beneficial partnerships with investors both large and small.
As our market share increases, so does our investor base, and with this an increased obligation to ensure we operate with a clearly defined, yet ethical focus, whilst achieving profitable returns for our many investment partners and ourselves.
We aim to increase upon our success achieved to date and to continue to improve the lives of thousands of patients worldwide with our many ground-breaking, cutting-edge clinical research and development programs.
As part of this goal, we welcome the opportunity to discuss with you an Investor Relations' partnership that may be of interest to you.
Please feel free to visit our Press Release page which details some of our latest investment related articles or use the form below if you have any questions related to our Investor Relations' program or to sign up for our regular alerts.

Yours sincerely,
Harvey Millington
Chief Investment Offcer,
Remedium Bio-Technology.
harvey.millington@rembiotech.com
Telephone +1-587-487-5722

If you have a general quention or comment you would like to make to Remedium Bio-Technology, please click here.

Accredited by: